000			02282 a2200721 4500
005			20250517193403.0
264		0	_c20181115
008			201811s 0 0 eng d
022			_a1476-5608
024	7		_a10.1038/s41391-017-0029-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aFitzGerald, L M
245	0	0	_aGermline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases. _h[electronic resource]
260			_bProstate cancer and prostatic diseases _c06 2018
300			_a228-237 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aClinical Trials as Topic
650	0	4	_aCohort Studies
650	0	4	_aDNA Modification Methylases _xgenetics
650	0	4	_aDNA Repair Enzymes _xgenetics
650	0	4	_aFollow-Up Studies
650	0	4	_aGerm-Line Mutation
650	0	4	_aHumans
650	0	4	_aInterleukin-4 _xgenetics
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aPrognosis
650	0	4	_aProstatic Neoplasms _xgenetics
650	0	4	_aProto-Oncogene Proteins c-akt _xgenetics
650	0	4	_aSurvival Rate
650	0	4	_aTumor Suppressor Proteins _xgenetics
700	1		_aZhao, S
700	1		_aLeonardson, A
700	1		_aGeybels, M S
700	1		_aKolb, S
700	1		_aLin, D W
700	1		_aWright, J L
700	1		_aEeles, R
700	1		_aKote-Jarai, Z
700	1		_aGovindasami, K
700	1		_aGiles, G G
700	1		_aSouthey, M C
700	1		_aSchleutker, J
700	1		_aTammela, T L
700	1		_aSipeky, C
700	1		_aPenney, K L
700	1		_aStampfer, M J
700	1		_aGronberg, H
700	1		_aWiklund, F
700	1		_aStattin, P
700	1		_aHugosson, J
700	1		_aKaryadi, D M
700	1		_aOstrander, E A
700	1		_aFeng, Z
700	1		_aStanford, J L
773	0		_tProstate cancer and prostatic diseases _gvol. 21 _gno. 2 _gp. 228-237
856	4	0	_uhttps://doi.org/10.1038/s41391-017-0029-2 _zAvailable from publisher's website
999			_c27945862 _d27945862